Diclofenac reduces the risk of Alzheimer’s disease: a pilot analysis of NSAIDs in two US veteran populationsOlaf Stüve, Bertis B. Little, Rick Weideman et al.|Therapeutic Advances in Neurological Disorders|2020Cited by 42
Microglia as a cellular target of diclofenac therapy in Alzheimer’s diseaseBarbara E. Stopschinski, Olaf Stüve, Rick Weideman et al.|Therapeutic Advances in Neurological Disorders|2023Cited by 26